Cargando…

How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study

INTRODUCTION: Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria. Its efficacy has been extensively assessed in clinical trials. In routine healthcare settings, however, its effectiveness can be diminished by delayed access to treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Challenger, Joseph D, Gonçalves, Bronner P, Bradley, John, Bruxvoort, Katia, Tiono, Alfred B, Drakeley, Chris, Bousema, Teun, Ghani, Azra C, Okell, Lucy C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936434/ https://www.ncbi.nlm.nih.gov/pubmed/31908862 http://dx.doi.org/10.1136/bmjgh-2019-001856

Ejemplares similares

Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
por: Challenger, Joseph D., et al.
Publicado: (2017)

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials
por: Okell, Lucy C, et al.
Publicado: (2008)

Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity
por: Okell, Lucy C, et al.
Publicado: (2008)

Factors determining the occurrence of submicroscopic malaria infections and their relevance for control
por: Okell, Lucy C., et al.
Publicado: (2012)

Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys
por: Whittaker, Charles, et al.
Publicado: (2021)

The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria
por: Okell, Lucy C., et al.
Publicado: (2011)

Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
por: Griffin, Jamie T., et al.
Publicado: (2010)

Haemolysis and haem oxygenase-1 induction during persistent “asymptomatic” malaria infection in Burkinabé children
por: Mooney, Jason P., et al.
Publicado: (2018)

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs
por: Bousema, Teun, et al.
Publicado: (2010)

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial
por: Tadesse, Fitsum G., et al.
Publicado: (2017)

Mathematical Modelling to Guide Drug Development for Malaria Elimination
por: Slater, Hannah C., et al.
Publicado: (2017)

Hitting Hotspots: Spatial Targeting of Malaria for Control and Elimination
por: Bousema, Teun, et al.
Publicado: (2012)

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis
por: Okell, Lucy C., et al.
Publicado: (2014)

Asymptomatic recrudescence after artemether–lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis
por: Mumtaz, Rida, et al.
Publicado: (2020)

Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
por: van Beek, Stijn W., et al.
Publicado: (2021)

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
por: Gonçalves, Bronner P., et al.
Publicado: (2016)

Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates
por: Stewart, Laveta, et al.
Publicado: (2009)

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial
por: Collins, Katharine A, et al.
Publicado: (2019)

Gametocyte Sex Ratio: The Key to Understanding Plasmodium falciparum Transmission?
por: Tadesse, Fitsum G., et al.
Publicado: (2019)

Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment
por: Bretscher, Michael T., et al.
Publicado: (2017)

Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission
por: Guelbéogo, Wamdaogo M, et al.
Publicado: (2018)

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

Estimating malaria transmission from humans to mosquitoes in a noisy landscape
por: Reiner, Robert C., et al.
Publicado: (2015)

Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)

Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models
por: Pothin, Emilie, et al.
Publicado: (2016)

A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria
por: Bretscher, Michael T, et al.
Publicado: (2014)

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
por: Chaccour, Carlos J, et al.
Publicado: (2013)

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso
por: Barry, Aissata, et al.
Publicado: (2019)

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Onward and upward
por: Gordon, Sharona E.
Publicado: (2019)

Onward to 2016
por: Jia, Shidong, et al.
Publicado: (2016)

Onwards and Upwards
por: Grapsa, Julia
Publicado: (2020)

Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials
por: White, Michael T, et al.
Publicado: (2010)

How Patients Take Malaria Treatment: A Systematic Review of the Literature on Adherence to Antimalarial Drugs
por: Bruxvoort, Katia, et al.
Publicado: (2014)

Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission
por: Mwesigwa, Julia, et al.
Publicado: (2019)

Determination of the Processes Driving the Acquisition of Immunity to Malaria Using a Mathematical Transmission Model
por: Filipe, João A. N, et al.
Publicado: (2007)

A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania
por: Shekalaghe, Seif A, et al.
Publicado: (2011)

Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya
por: Stevenson, Jennifer C., et al.
Publicado: (2015)

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria
por: Grignard, Lynn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rpn2o55d46mm5esotbn5bb5icv